Results
|
381.
|
|
|
382.
|
Skin Rash Can Be a Useful Marker for Afatinib Efficacy. [electronic resource] by
- Nasu, Shingo
- Suzuki, Hidekazu
- Shiroyama, Takayuki
- Tanaka, Ayako
- Iwata, Kaori
- Ryota, Noriko
- Ueda, Yuki
- Takata, S O
- Masuhiro, Kentaro
- Morita, Satomu
- Morishita, Naoko
- Okamoto, Norio
- Hirashima, Tomonori
Producer: 20180312
In:
Anticancer research vol. 38
Availability: No items available.
|
|
383.
|
Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report. [electronic resource] by
- Park, Cheol Kyu
- Hur, Jae Young
- Choi, Chang Min
- Kim, Tae Ok
- Cho, Hyun Ju
- Shin, Hong Joon
- Lim, Jung Hwan
- Choi, Yoo Duk
- Kim, Young Chul
- Oh, In Jae
Producer: 20180717
In:
Journal of Korean medical science vol. 33
Availability: No items available.
|
|
384.
|
BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors. [electronic resource] by
- Miele, Evelina
- Abballe, Luana
- Spinelli, Gian Paolo
- Besharat, Zein Mersini
- Catanzaro, Giuseppina
- Chiacchiarini, Martina
- Vacca, Alessandra
- Po, Agnese
- Capalbo, Carlo
- Ferretti, Elisabetta
Producer: 20201123
In:
BMC cancer vol. 20
Availability: No items available.
|
|
385.
|
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. [electronic resource] by
- Sequist, Lecia V
- Yang, James Chih-Hsin
- Yamamoto, Nobuyuki
- O'Byrne, Kenneth
- Hirsh, Vera
- Mok, Tony
- Geater, Sarayut Lucien
- Orlov, Sergey
- Tsai, Chun-Ming
- Boyer, Michael
- Su, Wu-Chou
- Bennouna, Jaafar
- Kato, Terufumi
- Gorbunova, Vera
- Lee, Ki Hyeong
- Shah, Riyaz
- Massey, Dan
- Zazulina, Victoria
- Shahidi, Mehdi
- Schuler, Martin
Producer: 20140505
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
386.
|
|
|
387.
|
|
|
388.
|
|
|
389.
|
None [electronic resource] by
- Nakatani, Kaori
- Yamaoka, Toshimitsu
- Ohba, Motoi
- Fujita, Ken-Ichi
- Arata, Satoru
- Kusumoto, Sojiro
- Taki-Takemoto, Iori
- Kamei, Daisuke
- Iwai, Shinichi
- Tsurutani, Junji
- Ohmori, Tohru
Producer: 20191125
In:
Molecular cancer therapeutics vol. 18
Availability: No items available.
|
|
390.
|
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases. [electronic resource] by
- Tan, Wan-Ling
- Ng, Quan Sing
- Lim, Cindy
- Tan, Eng Huat
- Toh, Chee Keong
- Ang, Mei-Kim
- Kanesvaran, Ravindran
- Jain, Amit
- Tan, Daniel S W
- Lim, Darren Wan-Teck
Producer: 20190325
In:
BMC cancer vol. 18
Availability: No items available.
|
|
391.
|
|
|
392.
|
Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer. [electronic resource] by
- Cappuzzo, Federico
- Finocchiaro, Giovanna
- Grossi, Francesco
- Bidoli, Paolo
- Favaretto, Adolfo
- Marchetti, Antonio
- Valente, Maria Luisa
- Cseh, Agnieszka
- Clementi, Laura
- Massey, Dan
- Santoro, Armando
Producer: 20151208
In:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 10
Availability: No items available.
|
|
393.
|
|
|
394.
|
|
|
395.
|
|
|
396.
|
Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR. [electronic resource] by
- Mitsuoka, Shigeki
- Kawaguchi, Tomoya
- Kubo, Akihito
- Isa, Shun-ichi
- Asai, Kazuhisa
- Uji, Masato
- Watanabe, Tetsuya
- Sawa, Kenji
- Yoshimoto, Naoki
- Oka, Takako
- Nakai, Toshiyuki
- Suzumura, Tomohiro
- Tanaka, Hidenori
- Matsuura, Kuniomi
- Kimura, Tatsuo
- Yoshimura, Naruo
- Kudoh, Shinzoh
- Hirata, Kazuto
Producer: 20160629
In:
Expert opinion on pharmacotherapy vol. 17
Availability: No items available.
|
|
397.
|
|
|
398.
|
|
|
399.
|
|
|
400.
|
|